Clinical Trial Update: Safety of ENC-201-CED ENCRT [Phase 1]

View source ↗

Summary

Phase 1 safety update for ENC-201-CED ENCRT from Encellin in Type 1 diabetes. The trial is currently Active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• ENC-201-CED ENCRT

Snippet

Sponsor: Encellin | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: ACTIVE_NOT_RECRUITING